The early expressed HIV-1 genes regulate DNMT1 expression

Epigenetics

Volumn 3, Issue 3, 2008, Pages 149-156

  Youngblood, Ben ^a   Reich, Norbert O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP 1; DNMT1; Epigenetic; HIV; Methylation

Indexed keywords

COMPLEMENTARY DNA; DNA METHYLTRANSFERASE 1; RESVERATROL; TRANSCRIPTION FACTOR AP 1; VIRUS PROTEIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; DNA RESPONSIVE ELEMENT; ENDOCYTOSIS; EPIGENETICS; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; VIRAL GENETICS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 49249104521     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.3.3.6372     Document Type: Article

References (64)

1. Fitzpatrick DR, Wilson CB. Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 2003; 109:37-45.
2. Jeltsch A. Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases. Chem biochem 2002; 3 274-93.
3. Wilson CB, Makar KW, Shnyreva M, Fitzpatrick DR. DNA methylation and the expanding epigenetics of T cell lineage commitment. Semin Immunol 2005; 17:105-19.
4. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005; 2:4-11.
5. Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res 2000; 28:2108-13.
6. Wilson CB, Merkenschlager M. Chromatin structure and gene regulation in T cell development and function. Curr Opin Immunol 2006; 18:143-51.
7. Jones PA. Epigenetics in carcinogenesis and cancer prevention. Ann NY Acad Sci 2003; 983:213-9.
8. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28.
9. Urnov FD, Wolffe AP. Above and within the genome: epigenetics past and present. J Mammary Gland Biol Neoplasia 2001; 6:153-67.
10. Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006; 5:37-50.
11. McMillan NA, Chun RF, Siderovski DP, Galabru J, Toone WM, Samuel CE, Mak TW, Hovanessian AG, Jeang KT, Williams BR. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 1995; 213:413-24.
12. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000; 1:11-9.
13. Aubol BE, Reich NO. Murine DNA cytosine C(5)-methyltransferase in vitro studies of de novo methylation spreading. Biochem Biophys Res Commun 2003; 310:209-14.
14. Flynn J, Glickman JF, Reich NO. Murine DNA cytosine-C5 methyltransferase pre-steady-and steady-state kinetic analysis with regulatory DNA sequences. Biochemistry 1996: 35:7308-15.
15. Flynn J, Reich N. Murine DNA (cytosine-5-)-methyltransferase: steady-state and substrate trapping analyses of the kinetic mechanism. Biochemistry 1998; 37:15162-9.
16. Svedruzic ZM, Reich NO. DNA cytosine C5 methyltransferase Dnmt1: catalysis-dependent release of allosteric inhibition. Biochemistry 2005; 44:9472-85.
17. Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM. Predicting aberrant CpG island methylation. Proc Natl Acad Sci USA 2003; 100:12253-8.
18. Muegge K, Young H, Ruscetti F, Mikovits J. Epigenetic control during lymphold development and immune responses: aberrant regulation, viruses and cancer. Ann NY Acad Sci 2003; 983:55-70.
19. Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A, Matsuoka M. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2005; 2:64.
20. Verma M. Viral genes and methylation. Ann NY Acad Sci 2003; 983:170-80.
21. Duenas-Gonzalez A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer 2005; 4:38,
22. Fang JY, Mikovits JA, Bagni R, Petrow-Sadowski CL, Ruscetti FW. Infection of lymphold cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol 2001; 75:9753-61.
23. Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 2002; 99:10084-9.
24. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990; 11:176-80.
25. Jahner D, Jaenisch R. Retrovirus-induced de novo methylation of flanking host sequences correlates with gene inactivity. Nature 1985; 315:594-7.
26. Cota-Gomez A, Flores NC, Cruz C, Casullo A, Aw TY, Ichikawa H, Schaack J, Scheinman R, Flores SC. The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NFkappaB-dependent mechanism. J Biol Chem 2002; 277:14390-9.
27. Shen G, Jeong WS, Hu R, Kong AN. Regulation of Nrf2, NFkappaB and AP-1 signaling pathways by chemopreventive agents. Antioxid Redox Signal 2005; 7:1648-63.
28. Bakin AV, Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 1999; 283:387-90.
29. Bigey P, Ramchandani S, Theberge J, Araujo FD, Szyf M. Transcriptional regulation of the human DNA Methyltransferase (dnmt1) gene. Gene 2000: 242:407-18.
30. Mikovits JA, Young HA, Vertino P, Issa JP, Pitha PM, Turcoski-Corrales S, Taub DD, Petrow CL, Baylin SB, Ruscetti FW. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFNgamma) promoter and subsequent downregulation of IFNgamma production. Mol Cell Biol 1998; 18:5166-77.
31. INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas. Am J Pathol 2002; 161:1007-13.
32. Grulich AE, Li Y, McDonald AM, Correll PK, Law MG, Kaldor JM. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS 2001; 15:629-33.
33. Martinez-Delgado B, Fernandez-Piqueras J, Garcia MJ, Arranz E, Gallego J, Rivas C, Robledo M, Benitez J. Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma. Leukemia 1997; 11:425-8.
34. Steffens CM, Hope TJ. Localization of CD4 and CCR5 in living cells. J Virol 2003; 77:4985-91.
35. StefFens CM, Hope TJ. Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events. J Virol 2004; 78:9573-8.
36. Kinter A, Arthos J, Cicala C, Fauci AS. Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunol Rev 2000; 177:88-98.
37. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, Laird PW. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001; 61:3410-8.
38. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38:787-93.
39. Wu Y, Marsh JW. Early transcription from nonintegrated DNA in human immunodeficiency virus infection. J Virol 2003; 77:10376-82.
40. Brigati C, Giacca M, Noonan DM, Albini A. HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol Lett 2003; 220:57-65.
41. Coiras M, Camafeita E, Urena T, Lopez JA, Caballero F, Fernandez B, Lopez-Huertas MR, Perez-Olmeda M, Alcami J. Modifications in the human T cell proteome induced by intracellular HIV-1 Tar protein expression. Proteomics 2006.
42. Domann FE, Rice JC, Hendrix MJ, Futscher BW. Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 2000; 85:805-10.
43. Kersh EN, Fitzpatrick DR, Murali-Krishna K, Shires J. Speck SH, Boss JM, Ahmed R. Rapid demethylation of the IFNgamma gene occurs in memory but not naive CD8 T cells. J Immunol 2006; 176:4083-93.
44. Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB. Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol 2003; 4:1183-90.
45. Ehrlich M, Woods CB, Yu MC, Dubeau L, Yang F, Campan M, Weisenberger DJ, Long T, Youn B, Fiala ES, faird PW. Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene 2006; 25:2636-45.
46. Rouleau J, Tanigawa G, Szyf M. The mouse DNA methyltransferase 5'-region. A unique housekeeping gene promoter. J Biol Chem 1992; 267:7368-77.
47. Rouleau J, MacLeod AR, Szyf M. Regulation of the DNA methyltransferase by the Ras-AP1 signaling pathway. J Biol Chem 1995; 270:1595-601.
48. Biggs TE, Cooke SJ, Barton CH, Harris MP, Saksela K, Mann DA. Induction of activator protein 1 (AP-1) in macrophages by human immunodeficiency virus type-1 NEF is a cell-type-specific response that requires both hck and MAPK signaling events. J Mol Biol 1999; 290:21-35.
49. Manninen A, Huotari P, Hiipakka M, Renkema GH, Saksela K. Activation of NFAT-dependent gene expression by Nef: conservation among divergent Nef alleles, dependence on SH3 binding and membrane association, and cooperation with protein kinase C-theta. J Virol 2001; 75:3034-7.
50. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics (Oxford, England) 2002; 18:333-4.
51. Varier RA, Kundu TK. Chromatin modifications (acetylation/deacetylation/ methylation) as new targets for HIV therapy. Curr Pharm Des 2006; 12:1975-93.
52. Baylin SB, Belinsky SA, Herman JG. Aberrant methylation of gene promoters in cancer-concepts, misconcepts and promise. J Natl Cancer Inst 2000; 92:1460-1.
53. Robertson KD. DNA methylation, methyltransferases and cancer. Oncogene 2001; 20:3139-55.
54. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429:457-63.
55. Eferl R, Wagner EE AP-1: a double-edge sword in tumorigenesis. Nat Rev Cancer 2003; 3:859-68.
56. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3:768-80.
57. Manna SK, Mukhopadhyay A, Aggarwal BB. IFNalpha suppresses activation of nuclear transcription factors NFkappaB and activator protein 1 and potentiates TNF-induced apoptosis. J Immunol 2000; 165:4927-34.
58. Manna SK, Mukhopadhyay A, Aggarwal BB. Human chorionic gonadotropin suppresses activation of nuclear transcription factor-kappaB and activator protein-1 induced by rumor necrosis factor. J Biol Chem 2000; 275:13307-14.
59. Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 2005; 16:449-66.
60. Yu R, Hebbar V, Kim DW, Mandlekar S, Pezzuto JM, Kong AN. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways. Mol Pharmacol 2001; 60:217-24.
61. Krishnan V, Zeichner SL. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J Virol 2004; 78:9458-73.
62. Sadaie MR, Benter T, Wong-Staal F. Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1. Science 1988; 239:910-3.
63. Frankel AD, Pabo CO. Cellular uptake of the tar protein from human immunodeficiency virus. Cell 1988; 55:1189-93.
64. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28 32.